Nigerian-British businessman and social media personality Igho Ubiribo had undergone five penile filler procedures at a Bangkok clinic before his death, according to Thailand’s Department of Health Service Support.
The revelation followed an inspection of the clinic where Ubiribo received his final procedure before he died in March 2026 while on holiday in Thailand with his wife.
Ubiribo, who was also known by the names “Tiny,” “Denisi” and “Ego,” was 43.
According to Thailand’s Ministry of Public Health, the clinic told investigators that Ubiribo had been receiving treatment there since 2024 and had undergone five injections intended to increase the size of his penis.
The first four procedures were reportedly carried out between 2024 and 2025, while the fifth took place on March 5, 2026, a day before his death.
Thai health authorities said the investigation began after emergency medical services received a request for an ambulance from a private hospital in Bangkok’s Sukhumvit area on March 5.
According to information provided by Ubiribo’s wife, he had received a penile filler injection earlier that day before going for a massage.
The hospital reportedly suspected a blood clot and prepared to conduct a CT scan with contrast dye to examine his blood vessels.
However, Ubiribo lost consciousness and had no pulse before the scan could be completed. Medical personnel began cardiopulmonary resuscitation but were unable to revive him.
The DHSS said the circumstances prompted authorities to inspect the clinic on September 7, 2026, as part of an investigation into the treatment and the events surrounding Ubiribo’s death.
The clinic told investigators that the final procedure involved 40cc of filler.
.
advertisement
According to the authorities, the doctor had recommended splitting the treatment into two sessions, but Ubiribo preferred to receive the injection in a single session.
The clinic said it provided him with post-procedure instructions and subsequently followed up with him, with no problems reported before his condition deteriorated.
It also said Ubiribo signed consent forms before each of the procedures.
The investigation was ordered after Thailand’s Minister of Public Health, Pattana Promphat, directed the Department of Health Service Support and the Food and Drug Administration to examine the clinic following Ubiribo’s death.
DHSS officials, working alongside the FDA, inspected the facility and reviewed its operations and available evidence.
DHSS Director-General Phuwadej Surakhot said the authorities would continue gathering evidence before referring the professional-practice aspect of the matter to Thailand’s Medical Council.
“We will gather all facts and evidence to proceed according to our authority and submit the case to the Medical Council for a ruling on professional practice standards, in order to ensure fairness to all parties,” the department said.
The Thai authorities have not announced any finding of malpractice against the clinic or the medical professionals involved.
Previous Findings Into Ubiribo’s Death
Ubiribo’s death had previously been examined in the United Kingdom, where evidence presented at a coroner’s inquest linked the cosmetic procedure to a fatal pulmonary embolism.
Reports on the case said approximately 40 millilitres of a filler containing hyaluronic acid and lidocaine had been injected during the final procedure.
After receiving the injection, Ubiribo and his wife reportedly returned to their hotel for a massage. He subsequently complained of chest pain and collapsed twice before being taken by ambulance to Sukhumvit Hospital.
Doctors suspected a pulmonary embolism and planned a CT scan, but his condition deteriorated before the examination could take place.
Medical personnel reportedly performed CPR for more than 100 minutes without success, and he died in the early hours of March 6.
A postmortem examination later found material in his lungs consistent with the hyaluronic acid used in the filler procedure.
Following the case, aesthetic medicine and dermatology physician Dr Mobola Savage warned that penile filler treatments carry medical risks.
“Non-surgical does not mean risk-free. Penile filler is still an invasive medical procedure involving highly vascular anatomy,” Savage said in a statement shared on X.
She explained that the treatment Ubiribo received was not conventional penile enlargement surgery but a non-surgical procedure designed mainly to increase penile girth.
The latest Thai investigation is focused on establishing the full circumstances surrounding Ubiribo’s death and determining whether the clinic and medical professionals involved complied with applicable professional and regulatory standards.